Our evaluation of the possible association between ET-1/ETAR expression and clinicopathological factors revealed that ET-1 was significantly more frequently positive in patients with highly invasive carcinoma, which is similar to the results of previous studies [11, 15, 16]. Here, EDN1 is linked to invasive carcinoma.